Procedure

2016 discharge: European Medicines Agency (EMA)

2017/2154(DEC)·8th term·CONT / ENVI·DEC - Discharge procedure·CompletedProcedure completed
Subjects: 2016 discharge
Rapporteur (the Member appointed to lead Parliament's work on this text): STAES Bart (Verts/ALE)
Summary

Decision on the 2016 discharge for the European Medicines Agency. Amendments grant, postpone or close the Agency's accounts and raise the Court of Auditors' findings on accounting transparency and procurement, the funding share from pharmaceutical-industry fees and related conflicts of interest, gender balance, IT consultants and reorganisations, whistleblowing, access to documents, clinical data transparency, and the impact of the United Kingdom's withdrawal and relocation to Amsterdam.

Procedure timeline

  1. Committee amendments tabled
    13 Dec 2017 – 2 Mar 2018
  2. Procedure completed
32
Amendments
distinct, in window
15
Members
tabled at least one
2
Committee(s)
13 Dec 2017 – 2 Mar 2018
Dates

Official amendment documents